| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Lyell Immunopharma, Inc. (LYEL) have been net sellers, shedding 14,188 shares worth roughly $215K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
The insider who sold still holds shares after the sale. LYEL sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.77M | - | - | |
| 10% | 1.43M | $36.53M | - | |
| 10% | 1.43M | $36.53M | - | |
| CEO | 63.9K | $993.0K | - | |
| Other | 20.4K | $259.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | Seely Lynn74 | President and CEO | Sell | 7,257 | $10.54 | $76,517.81 | -9.7% | +61.7% | +45.8% | |
| Aug 21, 2025 | Hill Stephen J. | Chief Operating Officer | Sell | 1,004 | $10.54 | $10,586.18 | -6.0% | +61.7% | +45.8% | |
| Aug 21, 2025 | Newton Charles W.66 | Chief Financial Officer | Sell | 1,453 | $10.54 | $15,320.43 | -8.7% | +61.7% | +45.8% | |
| Aug 21, 2025 | Lee Gary K. | Chief Scientific Officer | Sell | 1,453 | $10.54 | $15,320.43 | -8.6% | +61.7% | +45.8% | |
| Aug 12, 2025 | Seely Lynn74 | President and CEO | Sell | 797 | $10.43 | $8,312.89 | -2.2% | +67.3% | +34.1% | |
| Aug 12, 2025 | Hill Stephen J. | Chief Operating Officer | Sell | 185 | $10.43 | $1,929.64 | -2.0% | +67.3% | +34.1% | |
| Aug 12, 2025 | Lee Gary K. | Chief Scientific Officer | Sell | 267 | $10.43 | $2,784.87 | -2.9% | +67.3% | +34.1% | |
| Aug 12, 2025 | Newton Charles W.66 | Chief Financial Officer | Sell | 267 | $10.43 | $2,784.87 | -3.0% | +67.3% | +34.1% | |
| Mar 31, 2025 | Brawley Otis W | Director | Buy | 35,640 | $0.56 | $19,958.40 | New | -17.8% | +86.4% | |
| Mar 21, 2025 | Ramachandra Sumant | Director | Buy | 200,000 | $0.58 | $115,220.00 | New | -24.9% | +65.3% |